Meeting ReportPreclinical Probes for Oncology
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko and Hua Yang
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2356;
Luke Wharton
1TRIUMF Life Sciences Division
Scott McNeil
2TRIUMF
Gokce Engudar
2TRIUMF
Chengcheng Zhang
3BC Cancer
Michiel Van de Voorde
4SCK CEN
Maarten Ooms
Peter Kunz
2TRIUMF
Francois Benard
5BC Cancer Research Institute
Valery Radchenko
2TRIUMF

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko, Hua Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2356;
Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko, Hua Yang
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2356;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.